Replies to post #77814 on Savvy Trades and Investments

[swampboots]

IPIX : there is nothing at all scammy about your link. It implies a significant weighty event is about to happen, and the value of that statement probably had a 3 day life span for enhancing shareholder value a long time ago... Why?: Because the subtext is such: no antiviral new drug approved since 1987.
Brilacidin their drug never proved effective as an antiviral drug. Now they announced they will test it against the Covid-19,ha, so would I if it would enhance shareholder value by attesting to that plan, and help perhaps raise more money if price rose enough to allow for a secondary share addition, and who knows, throw enough hail Mary's at the big Covid and some semblance of a trace of eureka may dribble out?.

[RNsidersbuying]

IPIX / NBIO - I used 'scammy' more in a sense of the entire penny market.

IPIX announced good news - a pre-IND meeting with the FDA for Brilacidin while NBIO has an onging Phase 1 trial with it's Pritumumab. Being that Pritumumab and Brilacidin are both longshots...I'll take the 'Phase 1' over a 'pre-IND'...and the fact that NBIO also has a corroboration with a major University on a covid pre-clinical does seem to put NBIO in favor over IPIX

And when one contrasts the IPIX-$70M-cap against the NBIO-$5M-cap - NBIO becomes a no-brainer